Intellia Therapeutics, Inc. (FRA:38I)

Germany · Delayed Price · Currency is EUR

8.43

+0.21 (2.53%)

Last updated: Jan 6, 2026, 12:02 PM CET

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Genome Editing-based Therapies	57.88M	Log In	Log In	Log In	Log In	Upgrade
Genome Editing-based Therapies Growth	59.55%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
United States	57.88M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	59.55%	Log In	Log In	Log In	Log In	Upgrade